Collectively, these findings further support a role for Kaiso in TNBC cell proliferation. Open in a separate window Figure 2 Kaiso-depleted MDA-231 cells exhibit delayed tumor onset in mouse xenografts. the aggressive MDA-231 breast tumor cells. We further demonstrate that Kaiso depletion attenuates the survival of TNBC Trifloxystrobin cells and increases their propensity for apoptotic-mediated cell death. Notably, Kaiso Trifloxystrobin depletion downregulates BRCA1 expression in TNBC cells expressing mutant-p53 and we found that high Kaiso and BRCA1 expression correlates with a poor overall survival in breast malignancy patients. Collectively, our findings Trifloxystrobin reveal a role for Kaiso in the proliferation and survival of TNBC cells, and suggest a relevant role for Kaiso in the prognosis and treatment of TNBCs. Triple negative breast cancers (TNBC) symbolize a heterogeneous subtype of breast tumors that generally lack expression of estrogen receptor (ER), progesterone receptor (PR) and the human epidermal growth factor receptor 2.1 TNBCs are highly proliferative and have a high rate of recurrence compared to other breast malignancy (BCa) subtypes.2 Currently, you will find no specific targeted therapies for the management of TNBC, hence treatment is limited to radio- and chemotherapy. Although TNBCs in the beginning respond to chemotherapy, many patients relapse and this contributes to a ARPC3 shortened overall survival for affected patients.3 Numerous proteins have been implicated in the survival and chemo-resistant nature of TNBC. Two of the most understood are the tumor suppressors BRCA1 and p53.4, 5, 6 BRCA1 is mutated in ~45% of familial BCa7 and a high proportion of sporadic BCa, especially of the TNBC subtype.8, 9 However, some TNBCs retain the expression of wild-type (wt) BRCA1 (which plays a role in DNA repair) and this has been associated with their resistance to chemotherapeutic drugs such as Cisplatin.10 Similarly, p53 is mutated in ~30% of BCa11 with a higher frequency observed in TNBCs, reviewed in Walerych and effect of Kaiso depletion on TNBC cell proliferation would be sustained (Determine 1d). Nonetheless, consistent Trifloxystrobin with our proliferation studies, IHC analysis revealed reduced c-Myc and Cyclin D1 expression in Kaiso-depleted MDA-231 tumors compared to control MDA-231 tumor tissues (Figures 2c and d). Collectively, these findings further support a role for Kaiso in TNBC cell proliferation. Open in a separate window Physique 2 Kaiso-depleted MDA-231 cells exhibit delayed tumor onset in mouse xenografts. (a) Kaiso-depleted MDA-231 xenografts (sh-K) are delayed ~3 weeks in tumor onset and development compared to control (Ctrl) MDA-231 xenografted tumors as seen by time-course analysis of the tumor volume of Ctrl and sh-K MDA-231 xenografted cells. (b) IHC-stained images of MDA-231 xenograft tissues with Ki-67 and PCNA antibodies show a marked decrease in proliferating cells in MDA-231 Kaiso-depleted tumor tissues as indicated by the reduced expression of the proliferation markers Ki-67 and PCNA. (c and d) IHC-stained images of MDA-231 xenograft tissues with c-Myc and Cyclin D1 antibodies show that Kaiso-depletion results in reduced numbers of c-Myc and cyclin-D1 stained cells and reduced staining intensity. Representative images shown from 3 or more independent experiments Kaiso depletion induces apoptosis in TNBC cells As the delay in MDA-231 tumor onset could also have been due to increased apoptosis in Kaiso-depleted cells, we investigated the effect of Kaiso depletion around the expression of the apoptotic/cell-death markerCcleaved Caspase 3 (c-Caspase 3) in MDA-231 tumor tissues. Remarkably, we observed an increased quantity of c-Caspase 3 stained cells in Kaiso-depleted MDA-231 tumors compared to control MDA-231 tumors (Physique 3a). Quantification of the Caspase 3 activity of control and Kaiso-depleted (sh-K1 & sh-K2) MDA-231 cells using the Caspase 3 colorimetric assay, also revealed increased Caspase 3 activity in the Kaiso-depleted (sh-K1 & sh-K2) MDA-231 cells compared to control cells (Physique 3b). Similar results were also observed in Kaiso-depleted (sh-K1 & sh-K2) Hs578T cells compared to their control counterparts (Physique 3b). Further verification of Kaiso depletion effects on apoptosis with the Annexin V-fluorescein isothiocyanate (FITC) staining assay also confirmed that Kaiso depletion resulted in increased apoptosis of MDA-231 and Hs578T.